Last reviewed · How we verify
Induction of general anesthesia — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Amidate | Etomidate | Pfizer Inc. | General Anesthetic [EPC] | GABA A receptor alpha-2/beta-2/gamma-2 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 1 drug in Induction of general anesthesia
- Pfizer Inc. · 1 drug in Induction of general anesthesia
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Induction of general anesthesia:
- Induction of general anesthesia treatment updates — RSS
- Induction of general anesthesia treatment updates — Atom
- Induction of general anesthesia treatment updates — JSON
Cite this brief
Drug Landscape (2026). Induction of general anesthesia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/induction-of-general-anesthesia. Accessed 2026-06-10.
Related
- Induction of general anesthesia full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing